GeneChem Technologies Venture Fund L.P.

GeneChem Technologies Venture Fund L.P. was launched in early 1997 to capitalize on the growing opportunities offered by the emerging genomics sector. With $100 million in committed capital, this first dedicated fund invested in companies active in the genomics field, which the firm defined as gene discovery, functional genomics, bioinformatics, proteomics, and gene therapy.